Clinical Trial Update: Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study) [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating osteoporosis prevention in men with prostate cancer receiving androgen deprivation therapy. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Prostate Cancer

Snippet

Sponsor: University of Pittsburgh | Conditions: Prostatic Neoplasms | Phase 3 | Status: COMPLETED